Dillon C Cleary

Synthesis of Se-Adenosyl-L-Selenohomocysteine Selenoxide and Potential Gram-Negative Antibacterial Analogs

Dillon C Cleary, 2015 .

Antiviral Efficacy and Host Immune Response Induction during Sequential Treatment with SB 9200 Followed by Entecavir in Woodchucks

B. Kallakury, R. Iyer, N. Afdhal, 2017, PloS one.

Time to consider topical capsaicin for acute trauma pain?

Dillon C Cleary, S. Burton, Brock Cardon, 2022, The Journal of family practice.

Synthesis and characterization of Se-adenosyl-L-selenohomocysteine selenoxide

Z. Zhou, R. Duclos, Kalli C Catcott, 2015, Journal of sulphur chemistry.

Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activity.

P. Beuning, K. Takrouri, P. Zucchi, 2017, Bioorganic & medicinal chemistry letters.

Progress against Escherichia coli with the Oxazolidinone Class of Antibacterials: Test Case for a General Approach To Improving Whole-Cell Gram-Negative Activity.

P. Beuning, K. Takrouri, P. Zucchi, 2016, ACS infectious diseases.

Preclinical studies of SB 11285, a novel STING agonist for immuno-oncology.

D. Schmidt, G. Meher, R. Iyer, 2017 .

Antiviral Efficacy and Host Immune Response Induction with SB 9200, an Oral Prodrug of the Dinucleotide SB 9000, in Combination with Entecavir in the Woodchuck Model of Chronic Hepatitis B

R. Iyer, N. Afdhal, C. Yon, 2016 .